(Q37697810)

22 August 2017

1 reference

title

Natural and engineered kallikrein inhibitors: an emerging pharmacopoeia (English)

1 reference

22 August 2017

Joakim E Swedberg

1

1 reference

22 August 2017

Simon J de Veer

series ordinal

2

1 reference

22 August 2017

Jonathan M Harris

series ordinal

3

1 reference

22 August 2017

language of work or name

1 reference

1 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

391

1 reference

22 August 2017

4

1 reference

22 August 2017

357-374

1 reference

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation

22 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Peptide libraries: determination of relative reaction rates of protected amino acids in competitive couplings

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

DX-88 and HAE: a developmental perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Human and mouse proteases: a comparative genomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Targeting proteases: successes, failures and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Potent and selective peptidyl boronic acid inhibitors of the serine protease prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Discovering and improving novel peptide therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Expression of the kallikrein gene family in normal and Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Blockade of neuropsin, a serine protease, ameliorates kindling epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Recombinant hirudins: an overview of recent developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Sternal plating for the treatment of sternal nonunion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Synthetic inhibitors of human tissue kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Lessons learned in antifibrinolytic therapy: The BART trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Studies on plasma inhibitors of plasma kallikrfin using chromogenic peptide substrate assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Thermodynamics of BPTI folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Engineering of a macromolecular scaffold to develop specific protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Novel small molecule inhibitors for prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Intestinal tissue kallikrein-kallistatin profile in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Recent progress of the synthetic studies of biologically active marine cyclic peptides and depsipeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Delivery methods for peptide and protein toxins in insect control

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Genetic features of circular bacteriocins produced by Gram-positive bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Activity-based protein profiling: the serine hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Substrate specificity of human kallikreins 1 and 6 determined by phage display

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Activity of a newly identified serine protease in CNS demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Activity and stability of human kallikrein-2-specific linear and cyclic peptide inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

Distribution and evolution of circular miniproteins in flowering plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2010.037

21 January 2018

Identifiers

DOI

10.1515/BC.2010.037

1 reference

22 August 2017

1 reference